By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



600 West Chicago Avenue
Suite 775
Chicago  Ilinois  60654-2526  U.S.A.
Phone: n/a Fax: n/a


Tempus is a technology company that has built an operating system to battle cancer. Tempus enables physicians to deliver personalized cancer care through its interactive analytical and machine learning platform. The company provides genomic sequencing services and analyzes molecular and therapeutic data to empower physicians to make real-time, data-driven decisions. Our goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as we gather more data.




Co-Founder and CEO: Eric Lefkofsky

President: Dr. Kevin White

Chief Medical Informatics Officer: Dr. Jonathan Silverstein

COO: Ryan Fukushima

Director of Laboratory Operations: Sam Bettis

Scientific Adviser: Dr. Arul Chinnaiyan


Please click here for Tempus' job opportunities.

Key Statistics

Ownership: Private

Web Site: Tempus


Company News
Tempus And Cleveland Clinic Collaborate On Personalized Medicine Initiative 9/15/2017 10:00:58 AM
Tempus And UC Davis Comprehensive Cancer Center Announce Personalized Medicine Partnership For Cancer Patients 8/31/2017 10:54:19 AM
Tempus Selected As Sequencing And Analytics Provider By The Prostate Cancer Clinical Trials Consortium For Phase II Clinical Trial 8/17/2017 8:59:14 AM
Tempus Selected By University of Virginia As Partner For Large Granular Lymphocyte Leukemia Research Project 8/3/2017 11:19:07 AM
Tempus To Assist University of California, San Diego (UCSD) In Personalized Medicine Initiative 7/6/2017 11:18:21 AM
Tempus And University of Michigan Collaborate On Breast Cancer Initiative 6/8/2017 10:30:30 AM
Tempus And Northwestern Expand Partnership To Accelerate Personalized Medicine Efforts 5/12/2017 11:24:01 AM
Erik Phelps Joins Tempus As Executive Vice President And General Counsel 4/5/2017 12:53:23 PM
Tempus And University of Chicago Collaborate On Groundbreaking Breast Cancer Project 3/16/2017 8:08:55 AM
Tempus Teams With Major Academic Medical Center To Advance Treatment Options For Patients Diagnosed With Aggressive Brain Cancer 3/2/2017 7:41:54 AM